Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
The American Journal of Psychiatry
|
April 9, 2016
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B Singh, Maggie Fedgchin, Ella J Daly, et al.
The International Journal of Neuropsychopharmacology
|
July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.
Nature Neuroscience
|
October 28, 2016
Translating genome-wide association findings into new therapeutics for psychiatry
Gerome Breen, Qingqin Li, Bryan L Roth, et al.
The Journal of Clinical Psychiatry
|
April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
Ewa Wajs, Leah Aluisio, Richard Holder, et al.
JAMA Psychiatry
|
June 6, 2019
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial
Ella J Daly, Madhukar H Trivedi, Adam Janik, et al.
American Journal of Human Genetics
|
May 29, 2003
Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative
Danielle M Dick, Tatiana Foroud, Leah Flury, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 14, 2017
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis
Brian T D Tobe, Andrew M Crain, Alicia M Winquist, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
The American Journal of Psychiatry
|
April 9, 2016
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B Singh, Maggie Fedgchin, Ella J Daly, et al.
The International Journal of Neuropsychopharmacology
|
July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.
Nature Neuroscience
|
October 28, 2016
Translating genome-wide association findings into new therapeutics for psychiatry
Gerome Breen, Qingqin Li, Bryan L Roth, et al.
The Journal of Clinical Psychiatry
|
April 22, 2020
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
Ewa Wajs, Leah Aluisio, Richard Holder, et al.
JAMA Psychiatry
|
June 6, 2019
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial
Ella J Daly, Madhukar H Trivedi, Adam Janik, et al.
American Journal of Human Genetics
|
May 29, 2003
Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative
Danielle M Dick, Tatiana Foroud, Leah Flury, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 14, 2017
Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis
Brian T D Tobe, Andrew M Crain, Alicia M Winquist, et al.
Page
of 4